Work

Emerging photothermal agents combined with immunotherapy for cancer treatment

Year: 2025
Type: review
Abstract: BACKGROUND: Immunophotothermal therapy (IPTT), combining immune checkpoint inhibitors and photothermal therapy, represents a promising synergistic anticancer strategy that enhances tumour-specific immunity alongside localised thermal ablation. AIM: This review aims to summarise and critically analyse recent advancements in the development of photothermal agents for IPTT and their synergistic applications with immune checkpoint inhibitors. METHODS: We focus specifically on the progress in innovative photothermal agent materials, the underlying mechanisms of immunophotothermal synergy, and the resulting antitumor efficacy evidenced by preclinical and clinical findings. CONCLUSIONS: Furthermore, the key challenges hindering clinical translation and potential future directions are discussed. This comprehensive analysis highlights the current state and prospects of IPTT as an effective multimodal cancer treatment paradigm.
Language: English
Open Access status: gold
Estimated APC paid: $1,690
OpenAlex ID: W4415379727
FWCI: 0.328
Cites: 116
Cited by: 6
Related to: 10